Clinical Trials Browser

Melanoma × sitravatinib × Dermatologic × Clear all

NCT05104801 2021-11-04

Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma

Phase 2 Unknown

Melanoma